1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Diagnostic Imaging Market Trends
  5. > Global Nuclear Imaging Market

Global Nuclear Imaging Market

  • October 2016
  • -
  • Mordor Intelligence LLP
  • -
  • 124 pages

The global nuclear medicine diagnostic (PET and SPECT) market is expected to grow from an estimated $ 8.77 billion in 2014 to $ 15.51 billion in 2019, at an estimated compound annual growth rate (CAGR) of 12.08 %.Major factors for the growth of the market are increasing use of SPECT and PET analysis in radiopharmaceuticals, increased awareness of people for radiopharmaceuticals, and ready availability of radiopharmaceuticals.

Novel applications such as Alzheimers and continually expanding oncology application segment also drive the market. Till now, SPECT imaging was the mainstream modality for nuclear medicine applications like nuclear cardiology procedures. However, the trend is soon going to flip upside down because of global shortage of molybdenum-99 isotope which is in turn will lead to shortage of Technetium-99, which is the daughter product of molybdenum. Hence, PET imaging products which includes hybrid PET-CT scanners holds a potential market size in coming years. The cost associated with PET-CT service contract is usually 105 of the system purchase price annually and can be as high as $275,000 per year. The emerging market trend is fusion of nuclear imaging with different diagnostic imaging products such as PET/CT, SPECT/CT, and MRI/PET. This provides full gamut of imaging scans through the same unit and at the same time. PET market is expected to witness more growth compared to SPECT imaging as it provides higher resolution images and the lack of availability of technetium-99m is propelling industry to look for alternative diagnostic procedures.

Analyzing the application segment of SPECT and PET, PET is majorly being used in oncology because of good quality of imaging. While, SPECT is majorly used in cardiology segment accounting for almost 90% of the market share in cardiology. North America has 5729 PET procedures while the number of PET procedures in Asia-Pacific region is 369636 owing to the increased demand of nuclear medicine diagnostic procedures in developing nations. Market is segmented into two major segments SPECT (Technetium-99m (TC-99m), Thallium-201 (TL-201), Iodine (I-123) and others) and PET (Fluorine-18, Rubidium-82 (RB-82) and others). By application market is segmented into SPECT (cardiology, lymphoma, thyroid, neurology and others) and PET(oncology, cardiology, neurology and others).By geography market is segmented into North America, Europe and Asia-Pacific etc. North America accounts for the highest share of the global nuclear medicine diagnostic market; followed by Europe and Asia-Pacific. Asian countries are expected to show a growing trend in diagnostic sector because of increasing diagnostic procedure demand and rise in medical device industry.Major players in the market are Cardiarc Ltd., Digirad Corporation, Gamme Medica Inc., GE healthcare, Hologic Inc. etc. Mergers and acquisitions of small and medium sized manufacturers to enter in overseas market is another strategy adopted by multinational players.

Drivers: Major factors for the growth of the market are increasing use of SPECT and PET analysis in radiopharmaceuticals, increased awareness of people for radiopharmaceuticals, and ready availability of radiopharmaceuticals .Novel applications such as Alzheimer??s and continually expanding oncology application segment also drive the market.

Constraints: Some of the major constrains for the market are shorter half- life of radioisotopes, high capital investment, regulatory guidelines and reimbursement issues.



What the Report Offers:

1)Market Definition for the specified topic along with identification of key drivers and restraints for the market.

2)Market analysis for the Global Nuclear Imaging Market, with region specific assessments and competition analysis on a global and regional scale.

3)Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale. 4)Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.

5)Identification and analysis of the Macro and Micro factors that affect the Global Nuclear Imaging Market on both global and regional scale.

6)A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table Of Contents

Global Nuclear Imaging Market
1. Introduction

1.1 Report Description

1.2 Markets Covered

1.3 Research Methodology

2. Executive Summary

3. Market Overview

3.1 Market Definition

3.2 Market Drivers

3.3 Market Restraints

3.4 Market Opportunities

3.5 Threats

4. Porters Five Force Analysis

4.1 Bargaining Power of suppliers

4.2 Bargaining power of buyers

4.3 Degree of competition

4.4 Threat of substitution

4.5 Threat of new entrants

5. Market Segmentation

5.1 Africa Nuclear Imaging Market

5.1.1 By Diagnostic Technologies

5.1.1.1 SPECT Radioisotopes

5.1.1.1.1 Technetium-99m (TC-99m)

5.1.1.1.2 Thallium-201 (TL-201)

5.1.1.1.3 Iodine (I-123)

5.1.1.1.4 Others

5.1.1.2 PET Radioisotopes

5.1.1.2.1 Fluorine-18

5.1.1.2.2 Rubidium-82 (RB-82)

5.1.1.2.3 Others

5.1.2 By Applications

5.1.2.1 SPECT

5.1.2.1.1 Cardiology

5.1.2.1.2 Lymphoma

5.1.2.1.3 Thyroid

5.1.2.1.4 Neurology

5.1.2.1.5 Others

5.1.2.2 PET

5.1.2.2.1 Oncology

5.1.2.2.2 Cardiology

5.1.2.2.3 Neurology

5.1.2.2.4 Others

5.1.3 By Geography

5.1.3.1 North America

5.1.3.2 Europe

5.1.3.3 Asia-Pacific

5.1.3.4 Middle Easr

5.1.3.5 Africa

5.1.3.6 South America

6. Competitive Landscape

6.1 Mergers and Acquisitions

6.2 Agreements, Collaborations and Partnerships

6.3 New Product Launches

6.4 Recommendations to new market players

7. Company Profiles

7.1 AGFA-GEVAERT N.V.

7.2 CARDIARC LTD

7.3 DIGIRAD CORPORATION

7.4 GAMMA MEDICA INC

7.5 GE HEALTHCARE

7.6 HOLOGIC INC.

7.7 MEDX INC

7.8 NAVISCAN INC

7.9 POSITRON CORPORATION

7.10 SEGAMI CORPORATION

7.11 SIEMENS HEALTHCARE

LIST OF TABLES

1: GlobalNuclear Imaging Market($ million)(2014-2020).

2: GlobalNuclear Imaging Market- By Diagnostic Technologies-($ million)(2014-2020).

3: GlobalNuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-($ million)(2014-2020).

4: GlobalNuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Technetium-99m (TC-99m)-($ million)(2014-2020).

5: GlobalNuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Thallium-201 (TL-201)-($ million)(2014-2020).

6: GlobalNuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Iodine (I-123)-($ million)(2014-2020).

7: GlobalNuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Others-($ million)(2014-2020).

8: GlobalNuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-($ million)(2014-2020).

9: GlobalNuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Fluorine-18-($ million)(2014-2020).

10: GlobalNuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Rubidium-82 (RB-82)-($ million)(2014-2020).

11: GlobalNuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Others-($ million)(2014-2020).

12: GlobalNuclear Imaging Market- By Applications-($ million)(2014-2020).

13: GlobalNuclear Imaging Market- By Applications-SPECT-($ million)(2014-2020).

14: GlobalNuclear Imaging Market- By Applications-SPECT-Cardiology-($ million)(2014-2020).

15: GlobalNuclear Imaging Market- By Applications-SPECT-Lymphoma-($ million)(2014-2020).

16: GlobalNuclear Imaging Market- By Applications-SPECT-Thyroid-($ million)(2014-2020).

17: GlobalNuclear Imaging Market- By Applications-SPECT-Neurology-($ million)(2014-2020).

18: GlobalNuclear Imaging Market- By Applications-SPECT-Others-($ million)(2014-2020).

19: GlobalNuclear Imaging Market- By Applications-PET-($ million)(2014-2020).

20: GlobalNuclear Imaging Market- By Applications-PET-Oncology-($ million)(2014-2020).

21: GlobalNuclear Imaging Market- By Applications-PET-Cardiology-($ million)(2014-2020).

22: GlobalNuclear Imaging Market- By Applications-PET-Neurology-($ million)(2014-2020).

23: GlobalNuclear Imaging Market- By Applications-PET-Others-($ million)(2014-2020).

24: European Nuclear Imaging Market($ million)(2014-2020).

25: European Nuclear Imaging Market- By Diagnostic Technologies-($ million)(2014-2020).

26: European Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-($ million)(2014-2020).

27: European Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Technetium-99m (TC-99m)-($ million)(2014-2020).

28: European Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Thallium-201 (TL-201)-($ million)(2014-2020).

29: European Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Iodine (I-123)-($ million)(2014-2020).

30: European Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Others-($ million)(2014-2020).

31: European Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-($ million)(2014-2020).

32: European Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Fluorine-18-($ million)(2014-2020).

33: European Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Rubidium-82 (RB-82)-($ million)(2014-2020).

34: European Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Others-($ million)(2014-2020).

35: European Nuclear Imaging Market- By Applications-($ million)(2014-2020).

36: European Nuclear Imaging Market- By Applications-SPECT-($ million)(2014-2020).

37: European Nuclear Imaging Market- By Applications-SPECT-Cardiology-($ million)(2014-2020).

38: European Nuclear Imaging Market- By Applications-SPECT-Lymphoma-($ million)(2014-2020).

39: European Nuclear Imaging Market- By Applications-SPECT-Thyroid-($ million)(2014-2020).

40: European Nuclear Imaging Market- By Applications-SPECT-Neurology-($ million)(2014-2020).

41: European Nuclear Imaging Market- By Applications-SPECT-Others-($ million)(2014-2020).

42: European Nuclear Imaging Market- By Applications-PET-($ million)(2014-2020).

43: European Nuclear Imaging Market- By Applications-PET-Oncology-($ million)(2014-2020).

44: European Nuclear Imaging Market- By Applications-PET-Cardiology-($ million)(2014-2020).

45: European Nuclear Imaging Market- By Applications-PET-Neurology-($ million)(2014-2020).

46: European Nuclear Imaging Market- By Applications-PET-Others-($ million)(2014-2020).

47: Asia-Pacific Nuclear Imaging Market($ million)(2014-2020).

48: Asia-Pacific Nuclear Imaging Market- By Diagnostic Technologies-($ million)(2014-2020).

49: Asia-Pacific Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-($ million)(2014-2020).

50: Asia-Pacific Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Technetium-99m (TC-99m)-($ million)(2014-2020).

51: Asia-Pacific Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Thallium-201 (TL-201)-($ million)(2014-2020).

52: Asia-Pacific Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Iodine (I-123)-($ million)(2014-2020).

53: Asia-Pacific Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Others-($ million)(2014-2020).

54: Asia-Pacific Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-($ million)(2014-2020).

55: Asia-Pacific Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Fluorine-18-($ million)(2014-2020).

56: Asia-Pacific Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Rubidium-82 (RB-82)-($ million)(2014-2020).

57: Asia-Pacific Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Others-($ million)(2014-2020).

58: Asia-Pacific Nuclear Imaging Market- By Applications-($ million)(2014-2020).

59: Asia-Pacific Nuclear Imaging Market- By Applications-SPECT-($ million)(2014-2020).

60: Asia-Pacific Nuclear Imaging Market- By Applications-SPECT-Cardiology-($ million)(2014-2020).

61: Asia-Pacific Nuclear Imaging Market- By Applications-SPECT-Lymphoma-($ million)(2014-2020).

62: Asia-Pacific Nuclear Imaging Market- By Applications-SPECT-Thyroid-($ million)(2014-2020).

63: Asia-Pacific Nuclear Imaging Market- By Applications-SPECT-Neurology-($ million)(2014-2020).

64: Asia-Pacific Nuclear Imaging Market- By Applications-SPECT-Others-($ million)(2014-2020).

65: Asia-Pacific Nuclear Imaging Market- By Applications-PET-($ million)(2014-2020).

66: Asia-Pacific Nuclear Imaging Market- By Applications-PET-Oncology-($ million)(2014-2020).

67: Asia-Pacific Nuclear Imaging Market- By Applications-PET-Cardiology-($ million)(2014-2020).

68: Asia-Pacific Nuclear Imaging Market- By Applications-PET-Neurology-($ million)(2014-2020).

69: Asia-Pacific Nuclear Imaging Market- By Applications-PET-Others-($ million)(2014-2020).

70: Middle Eastern Nuclear Imaging Market($ million)(2014-2020).

71: Middle Eastern Nuclear Imaging Market- By Diagnostic Technologies-($ million)(2014-2020).

72: Middle Eastern Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-($ million)(2014-2020).

73: Middle Eastern Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Technetium-99m (TC-99m)-($ million)(2014-2020).

74: Middle Eastern Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Thallium-201 (TL-201)-($ million)(2014-2020).

75: Middle Eastern Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Iodine (I-123)-($ million)(2014-2020).

76: Middle Eastern Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Others-($ million)(2014-2020).

77: Middle Eastern Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-($ million)(2014-2020).

78: Middle Eastern Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Fluorine-18-($ million)(2014-2020).

79: Middle Eastern Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Rubidium-82 (RB-82)-($ million)(2014-2020).

80: Middle Eastern Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Others-($ million)(2014-2020).

81: Middle Eastern Nuclear Imaging Market- By Applications-($ million)(2014-2020).

82: Middle Eastern Nuclear Imaging Market- By Applications-SPECT-($ million)(2014-2020).

83: Middle Eastern Nuclear Imaging Market- By Applications-SPECT-Cardiology-($ million)(2014-2020).

84: Middle Eastern Nuclear Imaging Market- By Applications-SPECT-Lymphoma-($ million)(2014-2020).

85: Middle Eastern Nuclear Imaging Market- By Applications-SPECT-Thyroid-($ million)(2014-2020).

86: Middle Eastern Nuclear Imaging Market- By Applications-SPECT-Neurology-($ million)(2014-2020).

87: Middle Eastern Nuclear Imaging Market- By Applications-SPECT-Others-($ million)(2014-2020).

88: Middle Eastern Nuclear Imaging Market- By Applications-PET-($ million)(2014-2020).

89: Middle Eastern Nuclear Imaging Market- By Applications-PET-Oncology-($ million)(2014-2020).

90: Middle Eastern Nuclear Imaging Market- By Applications-PET-Cardiology-($ million)(2014-2020).

91: Middle Eastern Nuclear Imaging Market- By Applications-PET-Neurology-($ million)(2014-2020).

92: Middle Eastern Nuclear Imaging Market- By Applications-PET-Others-($ million)(2014-2020).

93: African Nuclear Imaging Market($ million)(2014-2020).

94: African Nuclear Imaging Market- By Diagnostic Technologies-($ million)(2014-2020).

95: African Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-($ million)(2014-2020).

96: African Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Technetium-99m (TC-99m)-($ million)(2014-2020).

97: African Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Thallium-201 (TL-201)-($ million)(2014-2020).

98: African Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Iodine (I-123)-($ million)(2014-2020).

99: African Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Others-($ million)(2014-2020).

100: African Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-($ million)(2014-2020).

101: African Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Fluorine-18-($ million)(2014-2020).

102: African Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Rubidium-82 (RB-82)-($ million)(2014-2020).

103: African Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Others-($ million)(2014-2020).

104: African Nuclear Imaging Market- By Applications-($ million)(2014-2020).

105: African Nuclear Imaging Market- By Applications-SPECT-($ million)(2014-2020).

106: African Nuclear Imaging Market- By Applications-SPECT-Cardiology-($ million)(2014-2020).

107: African Nuclear Imaging Market- By Applications-SPECT-Lymphoma-($ million)(2014-2020).

108: African Nuclear Imaging Market- By Applications-SPECT-Thyroid-($ million)(2014-2020).

109: African Nuclear Imaging Market- By Applications-SPECT-Neurology-($ million)(2014-2020).

110: African Nuclear Imaging Market- By Applications-SPECT-Others-($ million)(2014-2020).

111: African Nuclear Imaging Market- By Applications-PET-($ million)(2014-2020).

112: African Nuclear Imaging Market- By Applications-PET-Oncology-($ million)(2014-2020).

113: African Nuclear Imaging Market- By Applications-PET-Cardiology-($ million)(2014-2020).

114: African Nuclear Imaging Market- By Applications-PET-Neurology-($ million)(2014-2020).

115: African Nuclear Imaging Market- By Applications-PET-Others-($ million)(2014-2020).

116: South American Nuclear Imaging Market($ million)(2014-2020).

117: South American Nuclear Imaging Market- By Diagnostic Technologies-($ million)(2014-2020).

118: South American Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-($ million)(2014-2020).

119: South American Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Technetium-99m (TC-99m)-($ million)(2014-2020).

120: South American Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Thallium-201 (TL-201)-($ million)(2014-2020).

121: South American Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Iodine (I-123)-($ million)(2014-2020).

122: South American Nuclear Imaging Market- By Diagnostic Technologies-SPECT Radioisotopes-Others-($ million)(2014-2020).

123: South American Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-($ million)(2014-2020).

124: South American Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Fluorine-18-($ million)(2014-2020).

125: South American Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Rubidium-82 (RB-82)-($ million)(2014-2020).

126: South American Nuclear Imaging Market- By Diagnostic Technologies-PET Radioisotopes-Others-($ million)(2014-2020).

127: South American Nuclear Imaging Market- By Applications-($ million)(2014-2020).

128: South American Nuclear Imaging Market- By Applications-SPECT-($ million)(2014-2020).

129: South American Nuclear Imaging Market- By Applications-SPECT-Cardiology-($ million)(2014-2020).

130: South American Nuclear Imaging Market- By Applications-SPECT-Lymphoma-($ million)(2014-2020).

131: South American Nuclear Imaging Market- By Applications-SPECT-Thyroid-($ million)(2014-2020).

132: South American Nuclear Imaging Market- By Applications-SPECT-Neurology-($ million)(2014-2020).

133: South American Nuclear Imaging Market- By Applications-SPECT-Others-($ million)(2014-2020).

134: South American Nuclear Imaging Market- By Applications-PET-($ million)(2014-2020).

135: South American Nuclear Imaging Market- By Applications-PET-Oncology-($ million)(2014-2020).

136: South American Nuclear Imaging Market- By Applications-PET-Cardiology-($ million)(2014-2020).

137: South American Nuclear Imaging Market- By Applications-PET-Neurology-($ million)(2014-2020).

138: South American Nuclear Imaging Market- By Applications-PET-Others-($ million)(2014-2020).

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Small Animal Imaging Market by Modality, Reagent - Global forecast to 2021

Small Animal Imaging Market by Modality, Reagent - Global forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global small animal imaging market is estimated to grow at a high CAGR of 6.2% during 2016-2021; and is projected to be valued at USD 910.4 million by 2021. Market growth in the global small animal ...

Global Nuclear Imaging Systems Equipment Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

Global Nuclear Imaging Systems Equipment Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

  • $ 3900
  • Industry report
  • September 2016
  • by Occams

The global nuclear imaging system and equipment market is estimated to reach $2.2 billion by 2022 and is expected to grow at CAGR of 5.6% during 2016-2022. The nuclear imaging system and equipment market ...

Global and Chinese Nuclear Imaging Systems Industry, 2016 Market Research Report

Global and Chinese Nuclear Imaging Systems Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Nuclear Imaging Systems Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Nuclear Imaging Systems industry ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.